Medical Xpress reports late stage results for Lilly's triple-action shot in patients with type 2 diabetes.
Recap by typeshit. Full story at Medical Xpress.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Pooling 37 phase 3 trials and over 50,000 adults, researchers found each point of weight lost tracked with about 0.37 mmHg lower systolic pressure.
Bloomberg reports Walmart will offer over 250 prescriptions free to staff, with the GLP-1 drugs limited to type 2 diabetes and needing prior authorization.
Loading…